Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03737981
Brief Title: Testing The Addition of a New Anti-cancer Drug, Venetoclax, to the Usual Treatment (Ibrutinib and Obinutuzumab) in Untreated, Older Patients With Chronic Lymphocytic Leukemia

First Submitted : November 9, 2018
First Submitted that Met QC Criteria : November 9, 2018
First Posted : November 12, 2018 (Estimate)

Last Update Submitted that Met QC Criteria : September 19, 2019
Last Update Posted : September 20, 2019 (Estimate)